Ascorbic acid and cancer: a review.

Abstract:

:Host resistance to neoplastic growth and invasiveness is recognized to be an important factor in determining the occurrence, the progress, and the eventual outcome of every cancer illness. The factors involved in host resistance are briefly reviewed, and the relationship between these factors and ascorbic acid metabolism is presented in detail. It is shown that many factors involved in host resistance to neoplasia are significantly dependent upon the availability of ascorbate.

journal_name

Cancer Res

journal_title

Cancer research

authors

Cameron E,Pauling L,Leibovitz B

subject

Has Abstract

pub_date

1979-03-01 00:00:00

pages

663-81

issue

3

eissn

0008-5472

issn

1538-7445

journal_volume

39

pub_type

历史文章,杂志文章,评审
  • Interaction of dietary fat and the thymus in the induction of mammary tumors by 7,12-dimethylbenz(a)anthracene.

    abstract::The interaction of dietary fat and the thymus in the induction of mammary tumors by dimethylbenz(a)anthracene has been examined in female Sprague-Dawley rats. In these experiments, rats fed diets of 0.5% (low fat), 5% (normal fat), or 20% (high fat) corn oil from weaning (21 days of age) were thymectomized or sham thy...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wagner DA,Naylor PH,Kim U,Shea W,Ip C,Ip MM

    更新日期:1982-04-01 00:00:00

  • Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer.

    abstract::Excess production of the proinflammatory IL6 has both local and systemic tumor-promoting activity in many cancers, including ovarian cancer. However, treatment of advanced ovarian cancer patients with a neutralizing IL6 antibody yielded little efficacy in a previous phase II clinical trial. Here, we report results tha...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-1801

    authors: Milagre CS,Gopinathan G,Everitt G,Thompson RG,Kulbe H,Zhong H,Hollingsworth RE,Grose R,Bowtell DD,Hochhauser D,Balkwill FR

    更新日期:2015-04-01 00:00:00

  • An experimental approach to relate a tumor-associated enzyme marker to tumor cell numbers.

    abstract::Alkaline phosphatase was monitored in 17 mice with s.c.-implanted tumors to relate the total circulating alkaline phosphatase to the total number of tumor cells in each mouse. There was a semilogarithmic relationship between the alkaline phosphatase units and the number of tumor cells. A time-independent standard plot...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hiramoto RN,Ghanta VK,Soong SJ,Hurst DC

    更新日期:1977-02-01 00:00:00

  • From MGUS to Multiple Myeloma, a Paradigm for Clonal Evolution of Premalignant Cells.

    abstract::Multiple myeloma (MM) is a treatable, but incurable, malignancy of plasma cells (PC) in the bone marrow (BM). It represents the final stage in a continuum of PC dyscrasias and is consistently preceded by a premalignant phase termed monoclonal gammopathy of undetermined significance (MGUS). The existence of this well-d...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-17-3115

    authors: van Nieuwenhuijzen N,Spaan I,Raymakers R,Peperzak V

    更新日期:2018-05-15 00:00:00

  • Immunohistochemical analysis of human pulmonary carcinomas using monoclonal antibody 44-3A6.

    abstract::A monoclonal antibody, 44-3A6, was raised against the human pulmonary adenocarcinoma cell line A549. This antibody recognizes a protein antigen at the cell surface, which is preserved after formalin fixation and paraffin embedding. Immunohistochemical staining of lung tissue with this antibody revealed diffuse immunor...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lee I,Radosevich JA,Ma YX,Combs SG,Rosen ST,Gould VE

    更新日期:1985-11-01 00:00:00

  • Pharmacokinetic and phase I evaluation of esorubicin (4'-deoxydoxorubicin) by continuous infusion over forty-eight hours in patients with leukemia.

    abstract::Sixteen patients with previously treated acute nonlymphocytic leukemia or chronic myelogenous leukemia in blast crisis were given one to three courses of esorubicin by continuous infusion over 48 h. Dosage levels extended from 35 to 85 mg/m2. Four patients showed partial responses of short duration. Nonhematological t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kreis W,Rottach C,Budman DR,Chan K,Schulman P,Allen SL,Weiselberg L,Vinciguerra V

    更新日期:1988-10-01 00:00:00

  • Identification of a positive regulatory element responsible for tissue-specific expression of prostate-specific antigen.

    abstract::The prostate-specific antigen (PSA) promoter (PSA-P) has been identified, characterized, and determined to be tissue specific. Compared with high expression of the genomic PSA gene in prostate cells, expression of the transgene driven by the putative PSA promoter is low. This suggests that the identified promoter may ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Pang S,Dannull J,Kaboo R,Xie Y,Tso CL,Michel K,deKernion JB,Belldegrun AS

    更新日期:1997-02-01 00:00:00

  • Distribution of non-Hodgkin's lymphoma in the United States between 1950 and 1975.

    abstract::Age-adjusted mortality rates for non-Hodgkin's lymphoma in counties of the contiguous United States were examined by sex and race during 1950 to 1975 and were correlated through 1969 with demographic and industrial data. Mortality was consistently elevated in counties with large populations, especially in those with h...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Cantor KP,Fraumeni JF Jr

    更新日期:1980-08-01 00:00:00

  • Interleukin-30/IL27p28 Shapes Prostate Cancer Stem-like Cell Behavior and Is Critical for Tumor Onset and Metastasization.

    abstract::Prostate cancer stem-like cells (PCSLC) are believed to be responsible for prostate cancer onset and metastasis. Autocrine and microenvironmental signals dictate PCSLC behavior and patient outcome. In prostate cancer patients, IL30/IL27p28 has been linked with tumor progression, but the mechanisms underlying this link...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-3117

    authors: Sorrentino C,Ciummo SL,Cipollone G,Caputo S,Bellone M,Di Carlo E

    更新日期:2018-05-15 00:00:00

  • alpha-Fetoprotein as a carrier protein in plasma and its bilirubin-binding ability.

    abstract::The bilirubin-binding ability of human alpha-fetoproteins, which were purified from fetal cord serum and from ascites fluid of a hepatoma-bearing patient, was examined by the difference spectrum and the Jacobsen peroxidase methods. The difference spectrum observed as a result of the specific binding of bilirubin to al...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Aoyagi Y,Ikenaka T,Ichida F

    更新日期:1979-09-01 00:00:00

  • Lysyl oxidase-related protein-1 promotes tumor fibrosis and tumor progression in vivo.

    abstract::The lysyl oxidase gene family members function as extracellular matrix modulating enzymes. We have found that another member of this family, lysyl oxidase related protein-1 (LOR-1), is highly expressed in metastatic breast cancer-derived cell lines but not in the nonmetastatic estrogen-dependent MCF-7 cells. Furthermo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Akiri G,Sabo E,Dafni H,Vadasz Z,Kartvelishvily Y,Gan N,Kessler O,Cohen T,Resnick M,Neeman M,Neufeld G

    更新日期:2003-04-01 00:00:00

  • The paradoxical association of regression with a poor prognosis in melanoma contrasted with a good prognosis in keratoacanthoma.

    abstract::Partial regression in cutaneous malignant melanoma has been reported by a number of observers, albeit not all, to be associated with a relatively poor prognosis; in contrast, a keratoacanthoma, which eventually regresses, does not metastasize. The Hammond effect could explain the possibly poor prognosis of the thin re...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Prehn RT

    更新日期:1996-03-01 00:00:00

  • CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation.

    abstract::CUB domain-containing protein 1 (CDCP1) is a membrane protein that is highly expressed in several solid cancers. We reported previously that CDCP1 regulates anoikis resistance as well as cancer cell migration and invasion, although the underlying mechanisms have not been elucidated. In this study, we found that expres...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-0220

    authors: Miyazawa Y,Uekita T,Hiraoka N,Fujii S,Kosuge T,Kanai Y,Nojima Y,Sakai R

    更新日期:2010-06-15 00:00:00

  • Detection of a polyoma virus-induced tumor-associated membrane antigen in mouse cells by the macrophage migration inhibition test.

    abstract::Soluble membrane fractions derived from polyoma tumor cells trigger lymphocytes, derived from polyoma-immunized animals, but not from nonimmunized controls, to release the lymphokine, macrophage migration-inhibitory factor. The reaction can be blocked by sera from polyoma-bearing animals. Absorption of these sera with...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ramqvist T,Dalianis T,Reinholdsson G,Klein G,Szigeti R

    更新日期:1986-10-01 00:00:00

  • Altered cell cycle phase distributions in cultured human carcinoma cells partially depleted of polyamines by treatment with difluoromethylornithine.

    abstract::We have studied the effects of partial polyamine depletion, induced by treatment with alpha-difluoromethylornithine (DFMO) on cell cycle phase distributions in five cultured human carcinoma cell lines. We used flow cytometry of cells stained with chromomycin-A3 and computer analysis to measure phase distributions of t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Seidenfeld J,Block AL,Komar KA,Naujokas MF

    更新日期:1986-01-01 00:00:00

  • Allelic loss on chromosome 17p and p53 mutations in human endometrial carcinoma of the uterus.

    abstract::To understand the involvement of allelic losses and inactivation of tumor suppressor genes for the development of endometrial carcinoma of the uterus (EC), 24 cases of EC were examined for loss of heterozygosity (LOH) using a total of 57 polymorphic DNA markers covering all 23 pairs of chromosomes. LOH was observed at...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Okamoto A,Sameshima Y,Yamada Y,Teshima S,Terashima Y,Terada M,Yokota J

    更新日期:1991-10-15 00:00:00

  • Inhibition of nuclear factor-kappaB activity by temozolomide involves O6-methylguanine induced inhibition of p65 DNA binding.

    abstract::The alkylating agent temozolomide, commonly used in the treatment of malignant glioma, causes cellular cytotoxicity by forming O(6)-methylguanine adducts. In this report, we investigated whether temozolomide alters the activity of the transcription factor nuclear factor-kappaB (NF-kappaB). Temozolomide inhibits basal ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-4496

    authors: Yamini B,Yu X,Dolan ME,Wu MH,Darga TE,Kufe DW,Weichselbaum RR

    更新日期:2007-07-15 00:00:00

  • Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.

    abstract::Epidermal growth factor receptor vIII (EGFRvIII) is a tumor-specific, ligand-independent, constitutively active variant of the EGFR. Its expression has been detected in gliomas and various other human malignancies. To more fully characterize the function and potential biological role of EGFRvIII in regulating cell pro...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Tang CK,Gong XQ,Moscatello DK,Wong AJ,Lippman ME

    更新日期:2000-06-01 00:00:00

  • Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis.

    abstract::The long-standing strategy for the treatment of metastatic prostate cancer has been to reduce androgenic stimulation of tumor growth by removal of the testes, the primary site of testosterone synthesis. However, a low level of androgenic stimulation may continue, even after castration, by the conversion of adrenal and...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Klus GT,Nakamura J,Li JS,Ling YZ,Son C,Kemppainen JA,Wilson EM,Brodie AM

    更新日期:1996-11-01 00:00:00

  • Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma.

    abstract::To identify methylation-mediated silencing of genes in hepatocellular carcinoma (HCC), we surveyed genes induced by treatment with 5-aza-2'-deoxycytidine (5-Aza-CdR) in six human hepatoma cell lines using cDNA microarray analysis and determined the methylation status of 5' CpG islands by bisulfite DNA sequencing or me...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fukai K,Yokosuka O,Chiba T,Hirasawa Y,Tada M,Imazeki F,Kataoka H,Saisho H

    更新日期:2003-12-15 00:00:00

  • 2-Amino-6-methoxypurine arabinoside: an agent for T-cell malignancies.

    abstract::Earlier studies have shown guanine arabinoside (ara-G) is an effective agent against growth of T-cell lines and freshly isolated human T-leukemic cells. However, poor water solubility of ara-G limits clinical use. 2-Amino-6-methoxypurine arabinoside (506U) is a water-soluble prodrug converted to ara-G by adenosine dea...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lambe CU,Averett DR,Paff MT,Reardon JE,Wilson JG,Krenitsky TA

    更新日期:1995-08-01 00:00:00

  • Mouse models of subcutaneous spleen reservoir for multiple portal venous injections to treat liver malignancies.

    abstract::Dog and rat animal models have been developed for repeated intravascular administrations to the liver. However, mice have generally been considered too small to use for these models. This study describes the development of mouse models that permit the establishment of liver metastases that can be subsequently treated ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-2631

    authors: Kasuya H,Kuruppu DK,Donahue JM,Choi EW,Kawasaki H,Tanabe KK

    更新日期:2005-05-01 00:00:00

  • Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1/2 inactivation.

    abstract::BRCA1 inactivation is a frequent event in basal-like breast carcinomas (BLC). However, BRCA1 can be inactivated by multiple mechanisms and determining its status is not a trivial issue. As an alternate approach, we profiled 65 BLC cases using single-nucleotide polymorphism arrays to define a signature of BRCA1-associa...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-12-1470

    authors: Popova T,Manié E,Rieunier G,Caux-Moncoutier V,Tirapo C,Dubois T,Delattre O,Sigal-Zafrani B,Bollet M,Longy M,Houdayer C,Sastre-Garau X,Vincent-Salomon A,Stoppa-Lyonnet D,Stern MH

    更新日期:2012-11-01 00:00:00

  • Expression of a novel human gene, human wings apart-like (hWAPL), is associated with cervical carcinogenesis and tumor progression.

    abstract::In Drosophila melanogaster, the wings apart-like (wapl) gene encodes a protein that regulates heterochromatin structure. Here, we characterize a novel human homologue of wapl (termed human WAPL; hWAPL). The hWAPL mRNA was predominantly expressed in uterine cervical cancer, with weak expression in all other normal and ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-03-3822

    authors: Oikawa K,Ohbayashi T,Kiyono T,Nishi H,Isaka K,Umezawa A,Kuroda M,Mukai K

    更新日期:2004-05-15 00:00:00

  • Hematological and biochemical action of tiazofurin (NSC 286193) in a case of refractory acute myeloid leukemia.

    abstract::A patient with refractory acute myeloid leukemia was treated with tiazofurin, an agent that causes inhibition of tumor cell proliferation by depressing GTP concentrations in the malignant cells. The initial dose of 1100 mg/m2 was ineffective clinically and biochemically. Dose escalations to 1650, 2200, and finally 330...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Tricot GJ,Jayaram HN,Nichols CR,Pennington K,Lapis E,Weber G,Hoffman R

    更新日期:1987-09-15 00:00:00

  • Nuclear matrix proteins in normal and breast cancer cells.

    abstract::The progression from normal breast epithelium to a malignant phenotype may depend on changes in genetic events as well as failure of host mechanisms. Intermediate biomarkers are needed to more effectively identify malignant progression as well as to develop the potential for more specific treatments and prevention str...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Khanuja PS,Lehr JE,Soule HD,Gehani SK,Noto AC,Choudhury S,Chen R,Pienta KJ

    更新日期:1993-07-15 00:00:00

  • The quest for the 1p36 tumor suppressor.

    abstract::Genomic analyses of late-stage human cancers have uncovered deletions encompassing 1p36, thereby providing an extensive body of literature supporting the idea that a potent tumor suppressor resides in this interval. Although several genes have been proposed as 1p36 candidate tumor suppressors, convincing evidence that...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-07-2095

    authors: Bagchi A,Mills AA

    更新日期:2008-04-15 00:00:00

  • Identification of high mobility group protein I(Y) as potential progression marker for prostate cancer by differential hybridization analysis.

    abstract::One of the major problems in the diagnosis of localized prostatic tumors is to predict the aggressiveness of an individual tumor, which is presumably associated with chance to progression. In an attempt to find molecular markers that are specific for aggressive prostatic cancer cells, we compared steady-state mRNA lev...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bussemakers MJ,van de Ven WJ,Debruyne FM,Schalken JA

    更新日期:1991-01-15 00:00:00

  • EphA2 reexpression prompts invasion of melanoma cells shifting from mesenchymal to amoeboid-like motility style.

    abstract::Eph tyrosine kinases instruct cell for a repulsive behavior, regulating cell shape, adhesion, and motility. Beside its role during embryogenesis, neurogenesis, and angiogenesis, EphA2 kinase is frequently up-regulated in tumor cells of different histotypes, including prostate, breast, colon, and lung carcinoma, as wel...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-1845

    authors: Parri M,Taddei ML,Bianchini F,Calorini L,Chiarugi P

    更新日期:2009-03-01 00:00:00

  • Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma.

    abstract::Interleukin (IL) 6 was measured in the serum of 138 patients with metastatic renal carcinoma before the initiation of IL-2 treatment. IL-6 was detectable in 66 patients with renal cancer (48%) and in only 8 of 70 normal adults (11%). Serum C reactive protein (CRP) and IL-6 levels are correlated, suggesting that IL-6 i...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Blay JY,Negrier S,Combaret V,Attali S,Goillot E,Merrouche Y,Mercatello A,Ravault A,Tourani JM,Moskovtchenko JF

    更新日期:1992-06-15 00:00:00